129 related articles for article (PubMed ID: 22293874)
1. Head and neck cancer: value of perfusion CT in depicting primary tumor spread.
Trojanowska A; Trojanowski P; Drop A; Jargiełło T; Klatka J
Med Sci Monit; 2012 Feb; 18(2):CR112-118. PubMed ID: 22293874
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell cancer of hypopharynx and larynx - evaluation of metastatic nodal disease based on computed tomography perfusion studies.
Trojanowska A; Trojanowski P; Bisdas S; Staśkiewicz G; Drop A; Klatka J; Bobek-Billewicz B
Eur J Radiol; 2012 May; 81(5):1034-9. PubMed ID: 21324623
[TBL] [Abstract][Full Text] [Related]
3. Perfusion CT for head and neck tumors: pilot study.
Rumboldt Z; Al-Okaili R; Deveikis JP
AJNR Am J Neuroradiol; 2005 May; 26(5):1178-85. PubMed ID: 15891181
[TBL] [Abstract][Full Text] [Related]
4. Preoperative
Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
[TBL] [Abstract][Full Text] [Related]
5. Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
Nesteruk M; Lang S; Veit-Haibach P; Studer G; Stieb S; Glatz S; Hemmatazad H; Ikenberg K; Huber G; Pruschy M; Guckenberger M; Klöck S; Riesterer O
Radiother Oncol; 2015 Oct; 117(1):125-31. PubMed ID: 26452710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
7. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
Pietsch C; de Galiza Barbosa F; Hüllner MW; Schmid DT; Haerle SK; Huber GF; Studer G; Hany TF; Veit-Haibach P
BMC Med Imaging; 2015 Dec; 15():60. PubMed ID: 26714448
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results.
Gandhi D; Hoeffner EG; Carlos RC; Case I; Mukherji SK
J Comput Assist Tomogr; 2003; 27(5):687-93. PubMed ID: 14501359
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
10. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
Bisdas S; Spicer K; Rumboldt Z
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1376-81. PubMed ID: 18483187
[TBL] [Abstract][Full Text] [Related]
11. The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection of Primary Esophageal Carcinoma.
Genc B; Kantarci M; Sade R; Orsal E; Ogul H; Okur A; Aydin Y; Karaca L; Eroğlu A
Med Princ Pract; 2016; 25(3):254-9. PubMed ID: 26784024
[TBL] [Abstract][Full Text] [Related]
12. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
[TBL] [Abstract][Full Text] [Related]
13. CT perfusion in predicting treatment response of nasopharyngeal carcinoma.
Tuntiyatorn L; Fusuwankaya E; Sawangsilpa T; Bhongmakapat T
J Med Assoc Thai; 2014 Mar; 97(3):333-41. PubMed ID: 25123014
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography perfusion examination is helpful in evaluating the extent of oropharyngeal and oral cavity cancer.
Trojanowska A; Grzycka-Kowalczyk L; Trojanowski P; Klatka J; Drop A
Pol J Radiol; 2011 Jan; 76(1):14-9. PubMed ID: 22802811
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of contrast-enhanced CT and predictive factors for extracapsular spread in unknown primary head and neck squamous cell cancer.
Douglas C; Crosbie R; Young D; Montgomery J; O'Neill G; McArthur C
Clin Radiol; 2020 Jan; 75(1):77.e23-77.e28. PubMed ID: 31679816
[TBL] [Abstract][Full Text] [Related]
16. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy.
Hermans R; Meijerink M; Van den Bogaert W; Rijnders A; Weltens C; Lambin P
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1351-6. PubMed ID: 14630273
[TBL] [Abstract][Full Text] [Related]
17. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy.
Surlan-Popovic K; Bisdas S; Rumboldt Z; Koh TS; Strojan P
AJNR Am J Neuroradiol; 2010 Mar; 31(3):570-5. PubMed ID: 19875475
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.
Hoefling NL; McHugh JB; Light E; Kumar B; Walline H; Prince M; Bradford C; Carey TE; Mukherji SK
AJNR Am J Neuroradiol; 2013 May; 34(5):1062-6, S1-2. PubMed ID: 23370473
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of dynamic volume perfusion CT for differentiation of head and neck cancer from healthy tissue and post-therapeutic changes.
Troeltzsch D; Shnayien S; Gaudin R; Bressem K; Kreutzer K; Heiland M; Hamm B; Niehues S
Clin Hemorheol Microcirc; 2021; 78(1):93-101. PubMed ID: 33554889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
